Christian Dimaano
Senior Advisor at Brass Tacks Health- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Andy Kaufman
I had the privilege of collaborating with Christian on a recent annual meeting. He's a visionary leader that combines deep industry expertise with a commitment to developing his teams. He and his fellow leaders at Astellas have developed an impressive culture that is allowing them to be leaders in an industry that is rapidly changing. I highly recommend following Christian Dimaano as someone to get to know and learn from.
Andy Kaufman
I had the privilege of collaborating with Christian on a recent annual meeting. He's a visionary leader that combines deep industry expertise with a commitment to developing his teams. He and his fellow leaders at Astellas have developed an impressive culture that is allowing them to be leaders in an industry that is rapidly changing. I highly recommend following Christian Dimaano as someone to get to know and learn from.
Andy Kaufman
I had the privilege of collaborating with Christian on a recent annual meeting. He's a visionary leader that combines deep industry expertise with a commitment to developing his teams. He and his fellow leaders at Astellas have developed an impressive culture that is allowing them to be leaders in an industry that is rapidly changing. I highly recommend following Christian Dimaano as someone to get to know and learn from.
Andy Kaufman
I had the privilege of collaborating with Christian on a recent annual meeting. He's a visionary leader that combines deep industry expertise with a commitment to developing his teams. He and his fellow leaders at Astellas have developed an impressive culture that is allowing them to be leaders in an industry that is rapidly changing. I highly recommend following Christian Dimaano as someone to get to know and learn from.
Experience
-
Brass Tacks Health
-
United States
-
Business Consulting and Services
-
1 - 100 Employee
-
Senior Advisor
-
Oct 2023 - Present
-
-
-
University of Washington
-
United States
-
Higher Education
-
700 & Above Employee
-
Clinical Associate Professor
-
2016 - Present
Department of Health Systems & Population Health School of Public Health Department of Health Systems & Population Health School of Public Health
-
-
-
Kinnate Biopharma Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Vice President, Head of Medical Affairs
-
2023 - 2023
Head of Medical Affairs organization inclusive of medical communications and publications, medical operations and conference planning, patient advocacy, and field medical (MSL) external engagement Head of Medical Affairs organization inclusive of medical communications and publications, medical operations and conference planning, patient advocacy, and field medical (MSL) external engagement
-
-
-
Mirati Therapeutics
-
United States
-
Biotechnology Research
-
300 - 400 Employee
-
Executive Director, Head of Regional Medical Affairs
-
2021 - 2023
Head of Regional Medical Affairs organization with oversight of regional medical affairs directors, European medical science managers, training & operations, regional health outcomes directors, community oncology team, and patient advocacy Head of Regional Medical Affairs organization with oversight of regional medical affairs directors, European medical science managers, training & operations, regional health outcomes directors, community oncology team, and patient advocacy
-
-
-
Astellas Pharma US
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Director, Head of Field Medical US
-
2020 - 2021
Head of Field Medical organization in US Medical AffairsLeadership of field medical strategy and operations (including direct oversight of field excellence and HEOR functions) across therapeutic areas (oncology and non-oncology/specialty) with matrix management of multiple field teams (approximately 95 field based personnel (MSLs)
-
-
National Director, Oncology MSLs
-
2018 - 2020
MSL group leader of 4 Regional Field Directors and 26 Oncology MSLs across 2 Tumor Type Teams covering GU (prostate cancer, bladder cancer) and Rare Tumors (AML, gastric cancer)
-
-
-
Gilead Sciences
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Director, Medical Sciences
-
2016 - 2018
Team lead/manager of field team supporting Managed Care and Government Accounts (HEOR/payer-facing field medical team) covering Liver Disease (HCV, HBV, NASH), HIV/AIDS, Hematology/Oncology (CLL, FL, DLBCL) Team lead/manager of field team supporting Managed Care and Government Accounts (HEOR/payer-facing field medical team) covering Liver Disease (HCV, HBV, NASH), HIV/AIDS, Hematology/Oncology (CLL, FL, DLBCL)
-
-
-
Astellas Pharma US
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Field Director, Oncology MSLs
-
2015 - 2016
Team lead/manager of Oncology MSL team covering prostate cancer, lung cancer, AML Team lead/manager of Oncology MSL team covering prostate cancer, lung cancer, AML
-
-
-
Various Colleges & Universities
-
United States
-
Adjunct Faculty
-
2005 - 2016
Determinants of Health, University of Washington (2021 to present) Public Health/Health Disparities, California State University, East Bay (2017 to 2020) Cancer Biology, Utah Valley University (2011 to 2012) Introductory Cell & Molecular Biology, Salt Lake Community College (2010 to 2011) Fundamentals of Biology, Westminster College (2006 to 2007) Determinants of Health, University of Washington (2021 to present) Public Health/Health Disparities, California State University, East Bay (2017 to 2020) Cancer Biology, Utah Valley University (2011 to 2012) Introductory Cell & Molecular Biology, Salt Lake Community College (2010 to 2011) Fundamentals of Biology, Westminster College (2006 to 2007)
-
-
-
Bristol Myers Squibb
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Associate Director
-
Jan 2014 - Jun 2015
HEOR & Health Systems in support of Immuno-Oncology, Hematology/Oncology, Cardiovascular Disease, Virology, Immunology
-
-
Senior Medical Science Liaison
-
2011 - 2014
MSL in support of Immuno-Oncology (melanoma, NSCLC), Hematology/Oncology (CML, ALL, MM), and other solid tumors (Head & Neck and GI tumors)
-
-
-
Myriad Genetics
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Senior Scientist/Project Leader
-
2007 - 2011
Cancer target identification and validation *Myriad Pharmaceuticals division was spun-out from Myriad Genetics in 2009 and re-named Myrexis, Inc. in 2010 Cancer target identification and validation *Myriad Pharmaceuticals division was spun-out from Myriad Genetics in 2009 and re-named Myrexis, Inc. in 2010
-
-
Education
-
Cornell University
Executive Leadership Program -
University of Washington
Master of Public Health (MPH) -
University of Utah School of Medicine
Ph.D., Oncological Sciences -
California State University-East Bay
M.S., Biological Science - Immunology -
University of San Francisco
B.S., Biology